HF

Helen Fisher

Calix Limited | Non-Executive Director
Ms Fisher is a leader with a rare combination of financial expertise and knowledge and global networks in the Life Sciences sector. Helen is the founding CEO and Managing Director of Bio Capital Impact Fund (BCIF), and the Chair of the Victorian branch of AusBiotech. Helen was formerly a Non-Executive Director of Paradigm Biopharmaceuticals Ltd and a member of the American Chamber of Commerce in Australia Health Committee. Prior to establishing the BCIF, Helen was a partner of Deloitte and led Deloitte life sciences practice in Australia for 5 years, having had many years of experience in the life sciences and health care sector. She also specialised in the financial services sector, servicing banks and funds and has been involved in setting up a few international funds, as well as advised on a few M&A transactions. Helen has provided strategic tax advice to publicly listed and multinational companies and has experience with capital raisings, licensing deals, demergers, implementing offshore structures, IP and supply chain management.

Company and Role

Company
Title
Tenure
Since
CXL
Calix Limited
  • Non-Executive Director
6yrsSep 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CXL
Calix Limited
30/06/26N/A168,710N/AN/A
30/11/2310,20411,225766N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CXL
Calix Limited
05/12/25
Issued
112,500$0.600$67,500Director remuneration
CXL
Calix Limited
06/02/25
Buy
40,000$0.750$30,000Participation in share purchase plan
30/11/23
Issued
766$0.389$298Rights issue
30/11/23
Issued
1,021$0.429$438Rights issue
18/05/23
Buy
10,204$0.982$10,020On-market trade